Pradaxa Recall

Pradaxa profits, rather than patient safety push pill maker Boehringer Ingelheim to continue manufacturing and marketing this blood thinning agent. There is significant evidence that Pradaxa (dabigatran etexilate mesylate)) causes serious side effects and even death due to internal bleeding caused by the drug. Even so, the drug has reached blockbuster status with sales of […]

Read more